Kazuo Okadome

1.6k total citations · 1 hit paper
24 papers, 996 citations indexed

About

Kazuo Okadome is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Kazuo Okadome has authored 24 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 16 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Kazuo Okadome's work include Cancer Immunotherapy and Biomarkers (11 papers), Esophageal Cancer Research and Treatment (11 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Kazuo Okadome is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Esophageal Cancer Research and Treatment (11 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Kazuo Okadome collaborates with scholars based in Japan, United States and China. Kazuo Okadome's co-authors include Yoshifumi Baba, Takatsugu Ishimoto, Naoya Yoshida, Masaaki Iwatsuki, Yuji Miyamoto, Hideo Baba, Masayuki Watanabe, Taisuke Yagi, Yuki Kiyozumi and Daichi Nomoto and has published in prestigious journals such as Cancer Research, Annals of Surgery and British Journal of Cancer.

In The Last Decade

Kazuo Okadome

23 papers receiving 993 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer

2018 292 citations Kazuo Okadome, Yoshifumi Baba et al. Annals of Surgery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazuo Okadome Japan	12	564	385	272	264	206	24	996
Taisuke Yagi Japan	14	546 1.0×	391 1.0×	314 1.2×	181 0.7×	198 1.0×	29	936
Cheng-Wen Hsiao Taiwan	15	279 0.5×	419 1.1×	155 0.6×	255 1.0×	204 1.0×	40	983
Marco Aurélio Vamondes Kulcsar Brazil	24	302 0.5×	547 1.4×	201 0.7×	262 1.0×	86 0.4×	93	1.4k
Claudia Parisi Italy	18	342 0.6×	369 1.0×	233 0.9×	193 0.7×	145 0.7×	47	1.2k
Shiki Fujino Japan	14	339 0.6×	262 0.7×	124 0.5×	145 0.5×	55 0.3×	83	675
Yu Dong China	14	455 0.8×	105 0.3×	389 1.4×	213 0.8×	106 0.5×	68	913
Jorge Baixauli Spain	21	575 1.0×	571 1.5×	222 0.8×	158 0.6×	50 0.2×	71	1.1k
Seiichiro Kai Japan	15	308 0.5×	328 0.9×	198 0.7×	91 0.3×	154 0.7×	43	905
Shinobu Kunugi Japan	14	188 0.3×	176 0.5×	312 1.1×	186 0.7×	74 0.4×	74	774
Keishi Nakamura Japan	14	227 0.4×	144 0.4×	168 0.6×	130 0.5×	105 0.5×	57	585

Countries citing papers authored by Kazuo Okadome

Since Specialization

Citations

This map shows the geographic impact of Kazuo Okadome's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuo Okadome with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuo Okadome more than expected).

Fields of papers citing papers by Kazuo Okadome

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuo Okadome. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuo Okadome. The network helps show where Kazuo Okadome may publish in the future.

Co-authorship network of co-authors of Kazuo Okadome

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuo Okadome. A scholar is included among the top collaborators of Kazuo Okadome based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuo Okadome. Kazuo Okadome is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Li, Keisuke Kosumi, Tsuyoshi Hamada, et al.. (2025). Long-term yogurt intake and colorectal cancer incidence subclassified by Bifidobacterium abundance in tumor. Gut Microbes. 17(1). 2452237–2452237. 5 indexed citations

Takashima, Yasutoshi, Kazuo Okadome, Koichiro Haruki, et al.. (2024). Enrichment of Bacteroides fragilis and enterotoxigenic Bacteroides fragilis in CpG island methylator phenotype-high colorectal carcinoma. Clinical Microbiology and Infection. 30(5). 630–636. 11 indexed citations

Takashima, Yasutoshi, Yu Imamura, Kazuo Okadome, et al.. (2024). Clinicopathological, molecular, and prognostic features of colorectal carcinomas with KRAS c.34G>T (p.G12C) mutation. Cancer Science. 115(10). 3455–3465. 4 indexed citations

Kosumi, Keisuke, Yoshifumi Baba, Kensuke Yamamura, et al.. (2023). Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer. British Journal of Cancer. 128(6). 1155–1165. 13 indexed citations

Nomoto, Daichi, Yoshifumi Baba, Yang Liu, et al.. (2022). Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway. Cancer Letters. 530. 59–67. 75 indexed citations

Liu, Yang, Yoshifumi Baba, Takatsugu Ishimoto, et al.. (2022). Gut microbiome in gastrointestinal cancer: a friend or foe?. International Journal of Biological Sciences. 18(10). 4101–4117. 52 indexed citations

Ugai, Tomotaka, Yasutoshi Takashima, Kazuo Okadome, et al.. (2022). Abstract B002: History of appendectomy and colorectal cancer oncidence, overall and by intratumoral fusobacterium nucleatum status. Cancer Research. 82(23_Supplement_1). B002–B002.

Nomoto, Daichi, Yoshifumi Baba, Kazuo Okadome, et al.. (2021). Prognostic Impact of PD-1 on Tumor-Infiltrating Lymphocytes in 433 Resected Esophageal Cancers. The Annals of Thoracic Surgery. 113(1). 286–294. 8 indexed citations

Okadome, Kazuo, Yoshifumi Baba, Daichi Nomoto, et al.. (2021). PD‐L1 and PD‐L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma. Cancer Science. 113(2). 399–410. 14 indexed citations

10.

Nomoto, Daichi, Yoshifumi Baba, Takahiko Akiyama, et al.. (2021). Adapted systemic inflammation score as a novel prognostic marker for esophageal squamous cell carcinoma patients. Annals of Gastroenterological Surgery. 5(5). 669–676. 11 indexed citations

11.

Okadome, Kazuo, Yoshifumi Baba, Daichi Nomoto, et al.. (2020). Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancers. British Journal of Cancer. 122(10). 1535–1543. 41 indexed citations

12.

Nomoto, Daichi, Yoshifumi Baba, Takahiko Akiyama, et al.. (2020). Outcomes of esophageal bypass surgery and self-expanding metallic stent insertion in esophageal cancer: reevaluation of bypass surgery as an alternative treatment. Langenbeck s Archives of Surgery. 405(8). 1111–1118. 5 indexed citations

13.

Baba, Yoshifumi, Daichi Nomoto, Kazuo Okadome, et al.. (2020). Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma. Cancer Science. 111(9). 3132–3141. 187 indexed citations

14.

Miyamoto, Yuji, Yukiharu Hiyoshi, Nobuya Daitoku, et al.. (2019). Naples Prognostic Score Is a Useful Prognostic Marker in Patients With Metastatic Colorectal Cancer. Diseases of the Colon & Rectum. 62(12). 1485–1493. 45 indexed citations

15.

Yagi, Taisuke, Yoshifumi Baba, Kazuo Okadome, et al.. (2019). Tumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancer. European Journal of Cancer. 111. 38–49. 92 indexed citations

16.

Kosumi, Keisuke, Yoshifumi Baba, Kazuo Okadome, et al.. (2019). Tumor Long-interspersed Nucleotide Element-1 Methylation Level and Immune Response to Esophageal Cancer. Annals of Surgery. 272(6). 1025–1034. 9 indexed citations

17.

Kalikawe, Rebecca, Yoshifumi Baba, Daichi Nomoto, et al.. (2019). Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer. Cancer Science. 110(12). 3727–3737. 10 indexed citations

18.

Kiyozumi, Yuki, Yoshifumi Baba, Kazuo Okadome, et al.. (2018). IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer. Annals of Surgery. 269(6). 1101–1108. 80 indexed citations

19.

Kosumi, Keisuke, Naoya Yoshida, Kazuo Okadome, et al.. (2018). Minimally invasive esophagectomy may contribute to long-term respiratory function after esophagectomy for esophageal cancer. Diseases of the Esophagus. 31(6). 8 indexed citations

20.

Okadome, Kazuo, Hiromitsu Hayashi, Takaaki Higashi, et al.. (2015). Intra-aortic balloon pump-assisted major hepatectomy in a case with coronary disease. Surgical Case Reports. 1(1). 112–112. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact